Spruce Street Capital Lp Top Holdings and 13F Report (2026) About Spruce Street Capital LpInvestment ActivitySpruce Street Capital Lp has $628.98 million in total holdings as of September 30, 2026.Spruce Street Capital Lp owns shares of 39 different stocks, but just 17 companies or ETFs make up 80% of its holdings.Approximately 25.74% of the portfolio was purchased this quarter.This quarter, Spruce Street Capital Lp has purchased 30 new stocks and bought additional shares in 8 stocks.Spruce Street Capital Lp sold shares of 0 stocks and completely divested from 0 stocks this quarter.Largest Holdings KINIKSA PHARMACEUTICALS INTL $68,497,203LB PHARMACEUTICALS INC $53,863,456Relay Therapeutics $53,863,456ALTO NEUROSCIENCE INC $42,802,526Alkermes $38,432,045 Largest New Holdings this Quarter M40527109 - Entera Bio $32,631,154 Holding67448A106 - OBSIDIAN THERAPEUTICS INC $17,161,717 Holding786700104 - SAGIMET BIOSCIENCES INC $13,832,000 Holding92941V407 - YARROW BIOSCIENCE INC $13,678,243 Holding23255M303 - KORSANA BIOSCIENCES INC $10,304,110 Holding Largest Purchases this Quarter Entera Bio 11,213,455 shares (about $32.63M)Zai Lab 763,048 shares (about $20.10M)OBSIDIAN THERAPEUTICS INC 1,249,943 shares (about $17.16M)Alkermes 404,595 shares (about $16.39M)SAGIMET BIOSCIENCES INC 1,400,000 shares (about $13.83M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSpruce Street Capital Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorKINIKSA PHARMACEUTICALS INTL$68,497,2030.0%918,07010.9%ORD SHS CL ALB PHARMACEUTICALS INC$53,863,456$1,097,377 ▲2.1%1,404,7798.6%COM SHSRLAYRelay Therapeutics$53,863,4560.0%2,984,1258.6%HealthcareALTO NEUROSCIENCE INC$42,802,526$8,259,236 ▲23.9%1,676,5586.8%COM SHSALKSAlkermes$38,432,045$16,394,189 ▲74.4%948,4716.1%HealthcareENTXEntera Bio$32,631,154$32,631,154 ▲New Holding11,213,4555.2%HealthcareDIANTHUS THERAPEUTICS INC$31,241,5490.0%354,8165.0%COMSVRASavara$27,770,816$9,955,524 ▲55.9%5,381,9414.4%HealthcareZLABZai Lab$27,450,442$20,098,685 ▲273.4%1,042,1584.4%HealthcareRLMDRelmada Therapeutics$26,058,960$1,963,654 ▲8.1%6,912,1914.1%HealthcarePCVXVaxcyte$17,414,0740.0%306,0472.8%HealthcareOBSIDIAN THERAPEUTICS INC$17,161,717$17,161,717 ▲New Holding1,249,9432.7%COMELVNEnliven Therapeutics$15,081,6350.0%329,0062.4%HealthcareENTAEnanta Pharmaceuticals$14,349,4750.0%1,088,7312.3%HealthcareSURROZEN INC$13,903,0470.0%432,0402.2%COM NEWSAGIMET BIOSCIENCES INC$13,832,000$13,832,000 ▲New Holding1,400,0002.2%COM SER AYARROW BIOSCIENCE INC$13,678,243$13,678,243 ▲New Holding607,3822.2%COMIFRXInflaRx$10,955,106$1,321,150 ▲13.7%6,086,1701.7%HealthcareKORSANA BIOSCIENCES INC$10,304,110$10,304,110 ▲New Holding338,9511.6%COMPERSPECTIVE THERAPEUTICS INC$10,158,3100.0%3,693,9311.6%COM NEWAN2 THERAPEUTICS INC$9,320,699$483,790 ▲5.5%1,752,0111.5%COMINHIBIKASE THERAPEUTICS INC$7,360,1940.0%3,581,6031.2%COM NEWSAB BIOTHERAPEUTICS INC$6,969,2510.0%2,198,5021.1%COM NEWIPSCCentury Therapeutics$6,940,9820.0%4,059,0541.1%HealthcareERASErasca$6,194,4800.0%422,5431.0%HealthcareACHVAchieve Life Sciences$5,959,3930.0%736,6370.9%HealthcareNERVMinerva Neurosciences$5,545,9250.0%1,655,5000.9%HealthcareRESEARCH ALLIANCE CORP III$5,415,0000.0%500,0000.9%ORD SHS CL ARESEARCH ALLIANCE CORP IV$5,400,000$5,400,000 ▲New Holding450,0000.9%CL A ORD SHSHELIX ACQUISITION CORP III$5,310,0000.0%500,0000.8%USD CL A ORD SHSATTOVIA THERAPEUTICS INC$3,912,976$3,912,976 ▲New Holding228,2950.6%COMALECAlector$3,886,9760.0%2,101,0680.6%HealthcareTCGX ACQUISITION CORP$3,753,000$3,753,000 ▲New Holding300,0000.6%ORD CL ALEXEO THERAPEUTICS INC$3,138,6440.0%928,5930.5%COMALUMIS INC$2,901,1220.0%392,5740.5%COMCRVSCorvus Pharmaceuticals$2,667,8590.0%231,5850.4%HealthcareJATT II ACQUISITION CORP$1,799,2000.0%160,0000.3%ORD SHSJATT III ACQUISITION CORP$1,653,000$1,653,000 ▲New Holding150,0000.3%ORD SHSLEONABIO INC$1,405,5130.0%393,7010.2%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.